PRNewsWire - Health

InterShunt Enrolls First Patient in New Heart Failure Study
Shatterproof Names Public Affairs and Health Leader Pam Jenkins as New CEO
WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL
NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing